LSI researchers have launched 20+ spinoffs, such as Tekmira, a publicly traded company advancing drug candidates for cancer and viral infections; TerraGen Discovery, acquired by Cubist Pharmaceuticals for $29M for its environmental drug discovery tech; and EnGene, securing $20M+ in venture funding for its mucosal immunotherapy platform targeting prevalent chronic diseases like IBD and diabetes.
For a list of some of the patented UBC technologies available for licensing and for more information contact Innovation UBC.
Research paves the way for safer colonoscopy bowel prep for people with compromised gut health
January 9, 2026
UBC scientists discover “distress signal” cells use when their power supply is failing
December 18, 2025
UBC researchers uncover how statins harm muscles—and how to stop it
November 26, 2025
UBC enzyme technology clears first human test toward universal donor organs for transplantation
October 8, 2025
UBC launches world’s first mushroom-powered, waterless toilet with help from Hallam Lab
October 2, 2025
Dr. Kayla King awarded Royal Society’s Francis Crick Medal
September 16, 2025
Dr. Emilia Lim investigates wildfire smoke’s health toll with Genome BC funding
September 9, 2025
Dr. Steven Hallam named 2025 UBC Wall Research Award recipient
September 8, 2025
Dr. Yossef Av-Gay’s team reveals 70-year-old Parkinson’s drug’s promise against Tuberculosis
August 29, 2025
Building an inclusive TA training program in the life sciences
August 25, 2025
LSI researchers awarded funding in Spring 2025 CIHR project grant competition
July 21, 2025
Dr. Jayachandran Kizhakkedathu awarded New Frontiers in Research Fund – Exploration Grant
July 14, 2025
LSI researchers awarded funding through NSERC grants
July 11, 2025
Dr. Ivan Robert Nabi awarded Distinguished Achievement award by the UBC Faculty of Medicine
June 24, 2025
Dr. Douglas Allan Receives co-funded grant from Alzheimer Society and Brain Canada
June 20, 2025